Rchr
J-GLOBAL ID:200901003155422219   Update date: Sep. 18, 2024

Morimoto Takeshi

モリモト タケシ | Morimoto Takeshi
Affiliation and department:
Job title: Professor of Medicine
Research theme for competitive and other funds  (15):
  • 2021 - 2024 潜在的な薬剤性有害事象を自動的に検出する汎用性の高いアルゴリズムに関する研究
  • 2020 - 2023 Clinical prediction rule to identify high-risk inpatients for adverse drug events and medication errors in pediatric inpatients
  • 2020 - 2023 Epidemiology of Adverse Event in Elderly Patients
  • 2017 - 2023 小児入院患者の周術期医原性有害事象に対する要因分析
  • 2018 - 2021 Investigating the detection methods for and incidences of adverse events looked over in daily practice
Show all
Papers (685):
  • Wei Xiong, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Tatsuya Nishikawa, Nobutaka Ikeda, et al. Utility of the Modified Ottawa Score for Identification of More Preferable Candidates of Extended Anticoagulation therapy in Cancer-associated Isolated Distal Deep Vein Thrombosis: Insight from the ONCO DVT Study. Journal of thrombosis and haemostasis : JTH. 2024
  • Yuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, et al. Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism. European journal of internal medicine. 2024. 127. 74-83
  • Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, et al. Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era. Journal of the American Heart Association. 2024. 13. 15. e034412
  • Hiroshi Mabuchi, Ryusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, et al. Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2. Journal of thrombosis and thrombolysis. 2024. 57. 6. 907-917
  • Ko Yamamoto, Hiroyuki Ueda, Daiji Uchiyama, Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, Hiroyuki Tabata, Kenichi Ishizu, Toru Morofuji, Masaomi Hayashi, et al. Cerebrovascular Disease Detected on Preprocedural Computed Tomography in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement. Journal of the American Heart Association. 2024. 13. 14
more...
MISC (34):
  • 吉本武史, 田中寛大, 高下純平, 井上学, 豊田一則, 今村博敏, 坂井信幸, 山上宏, 内田和孝, 吉村紳一, et al. Impact of Discrepant Infarct on Outcomes of Endovascular Therapy for Large Ischemic Core Stroke: RESCUE-Japan LIMIT. 脳血管内治療(Web). 2022. 7. Supplement
  • 岡田 定規, 森本 剛, 小川 久雄, 副島 弘文, 斎藤 能彦. 2型糖尿病患者におけるスタチン内服と発癌の関係. 糖尿病. 2021. 64. 1. 53-53
  • Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Kimura T. Demographics, management, and in-hospital outcomes of patients with hospitalized acute heart failure syndromes in the contemporary real clinical practice. Heart Failure 2019. 2019
  • 田巻 庸道, 近藤 博和, 田村 俊寛, 夜久 英憲, 山本 絵里香, 小笹 寧子, 犬塚 康孝, 森本 剛, 中川 義久, 加藤 貴雄, et al. 急性非代償性心不全患者において低ナトリウム血症の改善は1年転帰と関連しない(Hyponatremia Improvement was not Associated with One-year Outcomes in Patients with Acute Decompensated Heart Failure). 日本循環器学会学術集会抄録集. 2019. 83回. PJ077-2
  • Koji Nishida, Kenji Nakatsuma, Kazuya Kawai, Takeshi Morimoto, Takeshi Kimura. SECOND-GENERATION VERSUS FIRST-GENERATION DRUG-ELUTING STENTS IN PATIENTS ON HEMODIALYSIS. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2018. 71. 11. 1125-1125
more...
Books (3):
  • 査読者が教える医学論文のための研究デザインと統計解析
    中山書店 2017
  • 査読者が教える採用される医学論文の書き方
    中山書店 2013
  • 医療ヘルスケアのための決断科学-エビデンスと価値判断の統合
    医歯薬出版 2004
Professional career (3):
  • Doctor of Medicine (Kyoto University)
  • Master of Public Health (Harvard School of Public Health)
  • Doctor of Philosophy (Kyoto University)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page